It hasn't been the best quarter for Inari Amertron Berhad (KLSE:INARI) shareholders, since the share price has fallen 24% in that time. On the bright side the returns have been quite good over the ...

Q3 revenue of $153.4 million exceeded analyst expectations of $150.7 million. Q3's adjusted operating loss of $0.4 million contrasted with $4.8 million in income income in the same period last year.

Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced ...

Cibc World Markets Corp bought a new position in Inari Medical, Inc. (NASDAQ:NARI – Free Report) during the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 4,952 shares ...

Charles Schwab Investment Management Inc. grew its position in shares of Inari Medical, Inc. (NASDAQ:NARI – Free Report) by 2 ...

Johnson Fistel is currently undertaking an extensive investigation related to potential violations of shareholder rights involving certain companies that are facing securities class action lawsuits.

PETALING JAYA: Near-term challenges due to lacklustre smartphone shipment will continue to weigh on Inari Amertron Bhd, whose core earnings at RM255mil for the nine-month period of financial year ...

PETALING JAYA: Inari Amertron Bhd is expected to capitalise on the Chinese smartphone market via a joint venture in Yiwu, China. Meanwhile, its radio frequency (RF) segment is expected to pick up ...